GZR-102

N/A

Report date: 2025/10/28 16:57:31

Base Information

Drug NameGZR-102
Drug Alias Name基础胰岛素/GLP-1RA 固定比例复方周制剂GZR102GZR-102
ClassificationBiologics
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsInsulin receptor agonists
TargetsGlucagon-like peptide 1 receptorInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGan&Lee Pharmaceuticals Shandong Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGan&Lee Pharmaceuticals Shandong Co LtdOswaldo Cruz FoundationGan & Lee Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A